Recursion Pharmaceuticals Inc - Class A
NASDAQ: RXRX
$7.24
Closing Price on January 31, 2025
RXRX Stock Chart and Intraday Price
RXRX Stock Data
Asset Type | Stock |
Exchange | NASDAQ |
Currency | USD |
Country | USA |
Sector | LIFE SCIENCES |
Industry | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
Address | 41S RIO GRANDE STREET, SALT LAKE CITY, UT, US |
Fiscal Year End | December |
Latest Quarter | 12/31/2023 |
Market Cap | 2,765.35M USD |
Shares Outstanding | 208,284,000 |
RXRX Articles
Don’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive technology funds posting high double-digit percentage returns. Notably,...
Published:
Investors either love Cathie Wood or hate her. The founder of the Ark Invest family of exchange-traded funds can either be phenomenally successful or a dismal failure. While Wood formed her...
Published:
Discover Our Top AI Stocks
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.